The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, involves a complex complicated organic process. Initial routes focused on amino acid chain fragment coupling, utilizing solid-phase synthesis methodologies to build the long protein sequence. Subsequent investigation has explored various approaches, includi